Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look at the efficacy of afamelanotide, when combined with
narrow-band ultraviolet B (NB-UVB) light, in patients with nonsegmental vitiligo.
Afamelanotide is expected to speed up the repigmentation induced by NB-UVB light, leading to
reducing frequency and doses of NB-UVB.